Pronounced racial HIV disparities persist in the US, with some signs of slow improvement
African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir
Alendronate can prevent bone loss in people starting HIV treatment
Reformulated islatravir implant should provide PrEP for over a year
Large numbers now on Descovy PrEP in the United States
By 2030, a quarter of people taking HIV treatment in the US will be over 65 and most will have multiple health concerns
Ten-year Italian study shows that people with HIV remain undetectable for 97% of the time
Near point-of-care viral load tests slash waiting times in seven African countries
Binge drinking more likely to cause death or liver problems in people with HIV
